Cite
HARVARD Citation
Gozzetti, A. et al. (2017). Intravenous (IV) bortezomib infusion after non‐response to subcutaneous bortezomib administration can induce transitory responses in multiple myeloma patients: are some patients more sensitive to IV bortezomib?. British journal of haematology. pp. 144-147. [Online].